Gut and Inflammatory Bowel Disease · Inflammatory Bowel Disease
Lowe AM et al., 2009
Cycle Biomarkers · Hormonal Markers
Bryant GA et al., 2009
Breast Health · Breast Cancer Risk
Rosenberg L et al., 2009
Supplements and Botanicals · Herbal and Botanical Products
Ozgoli G et al., 2009
Effectiveness · Typical and Perfect Use
Fehring RJ, 2009
Safety and Risks · Birth Defects
Reefhuis J et al., 2009
Fracture Risk · Prevention
Langsetmo LA et al., 2009
Ovarian Hormones · Androgens
Mamas L et al., 2009
Bone Mineral Density · Measurement
Berger C et al., 2009
Outcomes and Effectiveness · Cumulative Versus Per Cycle Reporting
Malizia BA et al., 2009
Ovarian Hormones · Estrogen
Vigil P et al., 2009
Registries and Reporting · National Registry Data
Canadian Fertility and Andrology Society, 2009 · Report
Ovarian Hormones · Estrogen
Hooper L et al., 2009
Registries and Reporting · National Registry Data
Wang YA et al., 2009 · Report
Birth Outcomes · Maternal Morbidity
Magee LA et al., 2009
Luteal Phase · Luteal Phase Deficiency
Fatemi HM, 2009
Fehring RJ, 2009
Guo SW, 2009
Return of Fertility · Breastfeeding and Ovulation
Valeggia C et al., 2009
Registries and Reporting · National Registry Data
Deutsches IVF-Register e.V., 2009 · Report
Adams Hillard PJ, 2008
Cycle Physiology · Cycle Variability
Mikolajczyk RT et al., 2008
Oral Contraceptives · Metabolic Effects
Roberts SC et al., 2008
Safety and Risks · Procedural Safety
Maxwell KN et al., 2008
Harris MA et al., 2008
Fracture Risk · Risk Factors
Vestergaard P et al., 2008
Male Factor Treatment · Medical Management
van Casteren NJ et al., 2008
Reproductive Genetics · Chromosomal Abnormalities
Ferlin A et al., 2008
Policy and Regulation · Professional Standards
United Kingdom Parliament, 2008 · Report
Effectiveness · Typical and Perfect Use
Fehring RJ et al., 2008
Breast Health · Breast Cancer Risk
Lee E et al., 2008
Supplements and Botanicals · Antioxidant Supplements
Amin AF et al., 2008
Fracture Risk · Risk Factors
Vestergaard P et al., 2008
Reproductive Genetics · Chromosomal Abnormalities
Mancini A et al., 2008
Hormonal Agents · Gonadotropins
Foresta C et al., 2008
Oral Contraceptives · Metabolic Effects
Rietzschel E et al., 2008
Cycle Biomarkers · Hormonal Markers
Fehring RJ et al., 2008
Birth Outcomes · Maternal Mortality
Laberge PY, 2008
Pelvic Pain · Chronic Pelvic Pain
Wayne PM et al., 2008
Fracture Risk · Risk Factors
Langsetmo L et al., 2008
Breast Health · Breast Cancer Risk
Veneroso C et al., 2008
Evaluation · Diagnostic Workup
Stanford JB et al., 2008
Evaluation · Unexplained Infertility
Quaas A et al., 2008
Neuroendocrinology · Gonadotropins
El-Khayat HA et al., 2008
Oral Contraceptives · Autoimmune Disease Risk
Cornish JA et al., 2008
Safety and Risks · Neonatal and Birth Outcomes
Romundstad LB et al., 2008
Hormonal Agents · Progesterone and Progestins
Raviele KM, 2008
Gallegos G et al., 2008
Odeblad E et al., 2008
Male Endocrine and Genetic Factors · Genetic Causes of Male Infertility
Zuccarello D et al., 2008